NCT00368979 - Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects | Biotech Hunter

Enrollment

378

Participants

Timeline

Start Date

February 17, 2006

Primary Completion Date

December 1, 2007

Study Completion Date

December 6, 2007

Conditions

Prostatic Hyperplasia

Interventions

DRUG

Dutasteride

once daily

DRUG

Placebo

once daily

Trial Locations (26)

263-0043

GSK Investigational Site, Chiba

266-0031

GSK Investigational Site, Chiba

272-0107

GSK Investigational Site, Chiba

802-0077

GSK Investigational Site, Fukuoka

810-0001

GSK Investigational Site, Fukuoka

830-0027

GSK Investigational Site, Fukuoka

660-0052

GSK Investigational Site, Hyōgo

215-0021

GSK Investigational Site, Kanagawa

226-0025

GSK Investigational Site, Kanagawa

229-1103

GSK Investigational Site, Kanagawa

245-0015

GSK Investigational Site, Kanagawa

252-0804

GSK Investigational Site, Kanagawa

259-1132

GSK Investigational Site, Kanagawa

604-8436

GSK Investigational Site, Kyoto

542-0073

GSK Investigational Site, Osaka

562-0036

GSK Investigational Site, Osaka

584-0074

GSK Investigational Site, Osaka

871-0012

GSK Investigational Site, Ōita